NCT02614079

Brief Summary

This study is to objectively evaluate the success of a spinal cord stimulator (SCS) trial using testing (DSSEP) to determine if the paresthesia (tingling sensation) or pain reduction achieved correlates with the degree of stimulation.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 23, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 25, 2015

Completed
2 months until next milestone

Study Start

First participant enrolled

January 20, 2016

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 7, 2016

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 9, 2017

Completed
3 months until next milestone

Results Posted

Study results publicly available

February 19, 2018

Completed
Last Updated

March 15, 2018

Status Verified

January 1, 2018

Enrollment Period

11 months

First QC Date

November 23, 2015

Results QC Date

December 5, 2017

Last Update Submit

February 19, 2018

Conditions

Keywords

lumbagolow back painleg pain

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With Positive Collision

    Positive collision: 75% or greater decrease in amplitude from the baseline waveform. Centroparietal (CPz)-Popliteal Fossa (Fpz) cortical montage (images) will be used as primary montage to evaluate collision results.

    Day 1

Study Arms (1)

DSSEP

EXPERIMENTAL

DSSEP testing after SCS trial lead placement

Device: DSSEP

Interventions

DSSEPDEVICE

Collision testing after the placement of SCS leads

DSSEP

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A. Subject understands the procedures, agrees to participate in the study, and has signed and dated the informed consent form prior to the initiation of any study-related activities.
  • B. Subjects are male or female greater than 18 years old at the time of screening visit.
  • C. Pain in one or both lower extremities. D. Pain is not responding to conservative treatment such as physical therapy or medications.
  • E. Average pain rating of at least 4 on a scale 0 to 10, on average, prior to enrollment in the study.
  • F. Patient is mentally competent to make decisions.

You may not qualify if:

  • A. Female subject with childbearing potential (a premenopausal female, who is not surgically sterile).
  • B. Subjects who poorly cooperate or have any cognitive impairment. C. Patient with severe concomitant depression. D. Inability to communicate adequately with physician and /or study coordinator.
  • E. Patient is diagnosed with a psychiatric condition that will likely interfere with diagnostic accuracy of the workup protocol or with recovery following the anticipated procedure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Toledo

Toledo, Ohio, 43614, United States

Location

MeSH Terms

Conditions

Back PainLow Back Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Joseph Atallah, MD
Organization
University of Toledo Medical Center

Study Officials

  • Joseph N Atallah, MD

    Universtiy of Toledo

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 23, 2015

First Posted

November 25, 2015

Study Start

January 20, 2016

Primary Completion

December 7, 2016

Study Completion

November 9, 2017

Last Updated

March 15, 2018

Results First Posted

February 19, 2018

Record last verified: 2018-01

Data Sharing

IPD Sharing
Will not share

The study was terminated early due to lack of enrollment.

Locations